ArticleArchives of osteoporosis2018

Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study.

Stuart L Silverman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.